Position in ERAS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,696,643
+$770,793 QoQ
Shares Held
256,367
+5.7% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ERAS ranks #51 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,696,643 | 256,367 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,925,850 | 242,636 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $703,124 | 189,012 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $439,379 | 201,550 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $255,925 | 201,516 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $286,936 | 209,443 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $561,958 | 223,888 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $580,092 | 212,488 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $364,891 | 154,615 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $250,308 | 121,509 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $250,500 | 117,606 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $236,894 | 120,251 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $324,780 | 117,674 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $333,586 | 110,826 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $420,561 | 97,578 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $761,264 | 97,598 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $511,136 | 91,766 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $553,453 | 64,355 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $307,580 | 19,742 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $374,363 | 17,642 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||